Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?

키워드

참고문헌 (13)

1. Global Burden of Disease Liver Cancer Collaboration, "the burden of primary liver cancer and underlying etiologies from 1990 to 2015at the global, regional, and national level : results from the global burden of disease study 2015", JAMA Oncol, 3, pp.1683~1691 (2017)
2. 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
3. Dyson J, "Hepatocellular cancer : the impact of obesity, type 2 diabetes and a multidisciplinary team", J Hepatol, 60, pp.110~117 (2014)
4. Petrick JL, "International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007", Int J Cancer, 139, pp.1534~1545 (2016)
5. Rahul Kumar, "Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(2), pp.196~208 (2020), 대한간학회[DOI]
6. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
7. European Association for the Study of the Liver (EASL), "EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease", J Hepatol, 64, pp.1388~1402 (2016)
8. Korean Association for the Study of the Liver (KASL), "KASL clinical practice guidelines: management of nonalcoholic fatty liver disease", Clin Mol Hepatol, 19, pp.325~348 (2013)
9. Loomba R, "AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease : expert review", Gastroenterology (2020)
10. Ganne-Carrié N, "Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis", J Hepatol, 69, pp.1274~1283 (2018)
11. Stine JG, "Systematic review with meta-analysis : risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases", Aliment Pharmacol Ther, 48, pp.696~703 (2018)
12. Kanwal F, "Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease", Gastroenterology, 155, pp.1828~1837.e2 (2018)
13. Reig M, "Should patients with NAFLD", NASH be surveyed for HCC?, 2019, pp.103, 39~44

관련 논문AI추천